ImmusanT, Inc. Release: New Test In Celiac Disease Provides Powerful Tool For Diagnosis And Immune Monitoring
1/6/2014 9:52:33 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmusanT, a company focused on restoring tolerance to gluten and overcoming the need for gluten-free diet in patients with celiac disease, today announced that an article appearing in the February 2014 issue of the journal, Clinical & Experimental Immunology, features research findings demonstrating that a simple blood test may eventually be used for diagnosing celiac disease and monitoring new therapies. ImmusanT’s chief scientific officer, Bob Anderson, M.D., Ph.D., along with collaborators in Australia, led the study.
Help employers find you! Check out all the jobs and post your resume.
comments powered by